eConsent for kidney biopsy: impact on the patient experience
The patient experience of kidney biopsy: A randomised controlled trial evaluating video-assisted consent versus standard consent for percutaneous ultrasound-guided kidney biopsy in adults
Pedro Henrique Franca Gois
120 participants
Jul 21, 2021
Interventional
Conditions
Summary
Informed medical consent is how clinicians communicate important information to patients about procedures/treatments they are recommending. The process of communication is highly individualised, time consuming and at a pace that is usually set by the healthcare worker. It is therefore not surprising that patients report variable and inconsistent comprehension and understanding of clinicians’ explanations of procedures/treatments. The literature demonstrates that audiovisual consent, when used to supplement current methods, improves the patient experience, including higher satisfaction, better comprehension and less anxiety. We will, for the first time in the procedure of kidney biopsies, evaluate patient reported benefits of video-assisted electronic consent compared to a conventional consent process, that being a clinician consenting the patient.
Eligibility
Inclusion Criteria1
- All consecutive patients scheduled to undergo a percutaneous kidney biopsy will receive information about the study and be invited to participate. Those that agree will be required to sign written informed consent to proceed into the study.
Exclusion Criteria3
- < 18 years of age.
- Individuals not competent to consent or refuse to consent to medical treatment.
- Legally blindness (defined as having corrected acuity of no better than 6/60 and/or a vision field of no more than 10 degrees).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants in the video-assisted (intervention) group will watch a 6 minute audiovisual consent animation describing the procedure of percutaneous kidney biopsy. This will be shown prior to the participant's consultation with their doctor. Content of the animation video is based on the recently published national CARI guidelines and its translation into the kidney biopsy pathway, approved by the RBWH Forms Review Committee. The final video is structured into 10 sections: “reasons for kidney biopsy”, “preparing for kidney biopsy”, “the procedure”, “post-procedure”, “benefits”, “risks of not having a kidney biopsy”, “alternatives”, “risks of kidney biopsy”, “patients at increased risk of complications” and “conclusion”. The audio narrative steps the participant through what is displayed in the video. The visual content is augmented by written subtitles and captions.The patient-centric animation was developed in English and will be translated into five other commonly spoken languages (Vietnamese, Arabic, Mandarin, Cantonese and Spanish).
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12621000768897